Ke Shan, Wright John C, Kwon Glen S
Department of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, Wisconsin 53706-1322, USA.
Bioconjug Chem. 2007 Sep-Oct;18(5):1644-50. doi: 10.1021/bc700182t. Epub 2007 Aug 18.
Bovine carboxypeptidase A (CPA) conjugated with biotinylated poly(ethylene glycol) (PEG) has been synthesized and characterized in terms of stoichiometry and half-life of the avidin-biotin-PEG(s)-CPA complex. The half-lives for dissociation are 3.34 days for the avidin-biotin-PEG(3400)-CPA 1:1 complex, 3.65 days for the avidin-biotin-PEG(5000)-CPA 1:1 complex, 3.91 days for the avidin-biotin-PEG(3400)-CPA-PEG(2000) 1:1 complex, and 2.74 days for the avidin-biotin-PEG(5000)-CPA-PEG(2000) 1:1 complex. The slow dissociation demonstrates the stability of complexes using a PEGylated biotin terminus as a linker with avidin. The stoichiometry of the biotin-PEGylated CPA with avidin was determined by the 2,6-ANS method, and the results are consistent with measurements of the stoichiometry using size exclusion chromatography. The stoichiometries are 1:2 for the avidin-biotin-PEG(3400)-CPA complex and the avidin-biotin-PEG(3400)-CPA-PEG(2000) complex, 1:1 for the avidin-biotin-PEG(5000)-CPA complex, and 1:4 for the avidin-biotin-PEG(5000)-CPA-PEG(2000) complex. These findings stress both the importance of the length of a PEG chain as an appropriate spacer between the biotin terminus and a functional group, and the great potential of the avidin-biotin-PEGylated-protein complex as a therapeutic protein delivery system for solid tumor prodrug targeting.
已合成了与生物素化聚乙二醇(PEG)偶联的牛羧肽酶A(CPA),并根据抗生物素蛋白-生物素-PEG(s)-CPA复合物的化学计量和半衰期对其进行了表征。抗生物素蛋白-生物素-PEG(3400)-CPA 1:1复合物的解离半衰期为3.34天,抗生物素蛋白-生物素-PEG(5000)-CPA 1:1复合物为3.65天,抗生物素蛋白-生物素-PEG(3400)-CPA-PEG(2000)1:1复合物为3.91天,抗生物素蛋白-生物素-PEG(5000)-CPA-PEG(2000)1:1复合物为2.74天。缓慢解离表明使用聚乙二醇化生物素末端作为与抗生物素蛋白连接子的复合物具有稳定性。通过2,6-ANS方法确定了生物素化聚乙二醇化CPA与抗生物素蛋白的化学计量,结果与使用尺寸排阻色谱法测量的化学计量一致。抗生物素蛋白-生物素-PEG(3400)-CPA复合物和抗生物素蛋白-生物素-PEG(3400)-CPA-PEG(2000)复合物的化学计量为1:2,抗生物素蛋白-生物素-PEG(5000)-CPA复合物为1:1,抗生物素蛋白-生物素-PEG(5000)-CPA-PEG(2000)复合物为1:4。这些发现强调了PEG链长度作为生物素末端与官能团之间合适间隔的重要性,以及抗生物素蛋白-生物素-聚乙二醇化蛋白复合物作为实体瘤前药靶向治疗性蛋白质递送系统的巨大潜力。